More recently, natural HDAC inhibitors such as short-chain fatty acids (SCFAs) have been considered for potential therapeutics for allergic asthma due to their immunomodulatory properties, mainly by suppressing the enzymatic activity of HDACs36,37. The gene discussed is HDAC9; the disease is allergic asthma.